Cerebral microbleeds are considered an imaging marker of cerebral small vessel disease. The location of microbleeds is thought to reflect the underlying pathology. Microbleeds in the deep and infratentorial region are thought to reflect hypertensive arteriopathy whereas lobar microbleeds are associated clinically with cerebral amyloid angiopathy (CAA). Aside from patient populations, microbleeds are frequently observed in seemingly asymptomatic populations. Moreover, many elderly, both in clinical and preclinical populations, have multiple coexisting pathologies in their brains, which complicates the interpretation of cerebral microbleeds, especially early in the clinical course. In this commentary, we discuss the influence of the strongest genetic risk factor for CAA, Apolipoprotein E (APOE), in the spatial distribution of microbleeds, and we additionally address issues in interpretation and implication of the location of microbleeds in clinical and asymptomatic populations.

, , , , , ,
doi.org/10.2478/s13380-014-0217-7, hdl.handle.net/1765/71978
Translational Neuroscience
Erasmus MC: University Medical Center Rotterdam

Loehrer, E., Vernooij, M., & Ikram, A. (2014). Cerebral microbleeds: Spatial distribution implications. Translational Neuroscience (Vol. 5, pp. 160–163). doi:10.2478/s13380-014-0217-7